# Bacteriophage Therapy in Patients With Urinary Tract Infections

> **NCT04287478** · PHASE1,PHASE2 · TERMINATED · sponsor: **Adaptive Phage Therapeutics, Inc.** · enrollment: 1 (actual)

## Conditions studied

- Urinary Tract Infection Bacterial

## Interventions

- **BIOLOGICAL:** Bacteriophage Therapy

## Key facts

- **NCT ID:** NCT04287478
- **Lead sponsor:** Adaptive Phage Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-09
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study terminated due to a change in development strategy.
- **Last updated:** 2023-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04287478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04287478, "Bacteriophage Therapy in Patients With Urinary Tract Infections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04287478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*